Related Experiment Video
Updated: Mar 7, 2026
06:32
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
8.3K
Molecular markers in glioma.
Kirsten Ludwig1,2, Harley I Kornblum3,4,5
1Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, USA.
Journal of Neuro-Oncology
|February 25, 2017
Summary
This review details molecular markers for brain tumors like gliomas and glioma stem cells (GSC). Understanding these markers is crucial for advancing brain cancer treatment and research.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cancer Research
Background:
- Gliomas are aggressive brain tumors causing most brain cancer deaths.
- Current treatments (radiation, temozolomide) offer limited survival benefits.
- Advances include identifying glioma stem cells (GSC) and understanding tumor heterogeneity.
Purpose of the Study:
- To provide a practical resource on molecular markers for glioma and GSC.
- To summarize known markers, their identification, and clinical relevance.
- To discuss the biology and identification methods for key markers.
Main Methods:
- Review of established molecular markers (MGMT, IDH, EGFR, etc.).
- Discussion of markers used to identify glioma stem cells (CD133, nestin, etc.).
- Exploration of identification techniques and biological significance.
Main Results:
- Several molecular markers are crucial for understanding glioma biology and heterogeneity.
- Specific markers aid in the identification of putative glioma stem cells.
- Significant knowledge gaps and conflicting reports exist in the literature.
Conclusions:
- Molecular markers are vital for glioma research and potential therapeutic targeting.
- No single marker can reliably identify all glioma stem cells across all gliomas.
- Further research is needed to clarify the role and application of these markers.
